Download - Cardiology Journal Club
![Page 1: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/1.jpg)
Cardiology Cardiology Journal ClubJournal Club
Sanjay Dravid, M.D.Sanjay Dravid, M.D.January 17, 2006January 17, 2006
![Page 2: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/2.jpg)
MULTIPLE BIOMARKERS MULTIPLE BIOMARKERS FOR THE PREDICTION OF FOR THE PREDICTION OF
FIRST MAJOR FIRST MAJOR CARDIOVASCULAR CARDIOVASCULAR
EVENTS AND DEATH EVENTS AND DEATH
Wang, Thomas J., et al. Wang, Thomas J., et al. Massachusetts General Hospital. Massachusetts General Hospital. NEJM. Volume 355(25), 21 NEJM. Volume 355(25), 21
December 2006, pp 2631-2639.December 2006, pp 2631-2639.
![Page 3: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/3.jpg)
OverviewOverview To evaluate the incremental To evaluate the incremental
usefulness of multiple biomarkers usefulness of multiple biomarkers from various pathways.from various pathways.
Established risk factors, including Established risk factors, including smoking, htn, DM, and dyslipidemia.smoking, htn, DM, and dyslipidemia.
Significant interest in new Significant interest in new biomarkers for risk stratification of biomarkers for risk stratification of ambulatory persons. ambulatory persons.
![Page 4: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/4.jpg)
Novel ApproachNovel Approach
Many individual biomarkers have Many individual biomarkers have been studied.been studied.
““Multimarker” ApproachMultimarker” Approach Simultaneous measurement may Simultaneous measurement may
enhance risk stratification?enhance risk stratification?
![Page 5: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/5.jpg)
Outcomes AnalysisOutcomes Analysis
1. Death from any cause1. Death from any cause 2. 12. 1stst Major cardiovascular event Major cardiovascular event
(MI, coronary insufficiency, heart (MI, coronary insufficiency, heart failure, and stroke.failure, and stroke.
Reviewed by a committee of three Reviewed by a committee of three investigators investigators
![Page 6: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/6.jpg)
Study SampleStudy Sample Large, community based cohort studyLarge, community based cohort study Participants from the sixth examination Participants from the sixth examination
cycle (1995-1998) of the Framingham cycle (1995-1998) of the Framingham Offspring Study Offspring Study
IRB of Boston University Medical IRB of Boston University Medical Center approval Center approval
Written informed consent was obtained Written informed consent was obtained H & P, PE, and Lab AssessmentH & P, PE, and Lab Assessment
![Page 7: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/7.jpg)
Exclusion CriteriaExclusion Criteria
Serum creatinine levels greater than Serum creatinine levels greater than 2.0 mg/dL2.0 mg/dL
Missing covariatesMissing covariates Prior event when determining Prior event when determining
outcome of major cardiovascular outcome of major cardiovascular eventevent
Triglycerides > 400Triglycerides > 400
![Page 8: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/8.jpg)
Biomarker Selection Biomarker Selection 1. Marker of inflammation- hsCRP1. Marker of inflammation- hsCRP 2. Markers of neurohormonal activity- 2. Markers of neurohormonal activity-
BNP, aldosterone, renin, N-terminal BNP, aldosterone, renin, N-terminal pro-atrial natriuretic peptidepro-atrial natriuretic peptide
3. Marker of thrombosis and 3. Marker of thrombosis and inflammation- fibrinogeninflammation- fibrinogen
4. Marker of fibrinolytic potential and 4. Marker of fibrinolytic potential and endothelial function- plasminogen-endothelial function- plasminogen-activator activator
![Page 9: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/9.jpg)
Biomarker cont’dBiomarker cont’d Inhibitor type 1Inhibitor type 1 5. Marker of thrombosis- D-dimer5. Marker of thrombosis- D-dimer 6. Marker of endotheial function and 6. Marker of endotheial function and
oxidant stress- homocysteineoxidant stress- homocysteine 7. Marker of glomerular endothelial 7. Marker of glomerular endothelial
function- urinary albumin-to-function- urinary albumin-to-creatinine ratio creatinine ratio
![Page 10: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/10.jpg)
![Page 11: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/11.jpg)
Lab ProtocolLab Protocol Fasting blood and urine samples Fasting blood and urine samples
collected in morning after patient collected in morning after patient supine for ~10 minutes. supine for ~10 minutes. Immediately centrifuged and stored Immediately centrifuged and stored at -70 degreesC. at -70 degreesC.
Standardized Assay MethodsStandardized Assay Methods
![Page 12: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/12.jpg)
Statistical AnalysisStatistical Analysis Multivariable proportional-hazards Multivariable proportional-hazards
model (2 sets of analyses for each model (2 sets of analyses for each outcome due to urine subgroups)outcome due to urine subgroups)
Logarithmic transformation used to Logarithmic transformation used to normalize the distribution of normalize the distribution of biomarkersbiomarkers
To reduce the number of false To reduce the number of false positives from multiple testing: positives from multiple testing:
![Page 13: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/13.jpg)
Statistics cont’dStatistics cont’d 1) Multivariable Cox regression model1) Multivariable Cox regression model 2) Backward elimination 2) Backward elimination 3) Construction of multimarker score3) Construction of multimarker score 4) Quintiles categorized 4) Quintiles categorized 5) Cumulative probability curves 5) Cumulative probability curves
constructed by the Kaplan-Meier constructed by the Kaplan-Meier method for low, intermediate and high method for low, intermediate and high mulitmarker scoresmulitmarker scores
![Page 14: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/14.jpg)
Statistics cont’dStatistics cont’d Then calculated hazard ratios for Then calculated hazard ratios for
death and major cardiovascular events death and major cardiovascular events for the mulitmarker score groups for the mulitmarker score groups
Adjusted for age, sex, conventional Adjusted for age, sex, conventional risk factors including htn, smoking, risk factors including htn, smoking, dm, etc.dm, etc.
““C statistic”C statistic” ROC curvesROC curves
![Page 15: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/15.jpg)
Statistics cont’dStatistics cont’d Secondary Analysis adjusting for Secondary Analysis adjusting for
medication usemedication use Repeated a Cox proportional-hazards Repeated a Cox proportional-hazards
model for major cardiovascular events model for major cardiovascular events adjusting for “nonmajor events” adjusting for “nonmajor events” angina, intermittent claudication, TIAangina, intermittent claudication, TIA
SAS software, version 8 (SAS SAS software, version 8 (SAS Institute) Institute)
![Page 16: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/16.jpg)
C StatisticC Statistic Defined as the probability of Defined as the probability of
concordanc among persons who can concordanc among persons who can be compared.be compared.
Estimated as the sum of Estimated as the sum of concordance values divided by the concordance values divided by the number of comparable pairs.number of comparable pairs.
Better able to measure Better able to measure discrimination than relative risk. discrimination than relative risk.
![Page 17: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/17.jpg)
ResultsResults Total of 3532 persons- 21 excluded for Total of 3532 persons- 21 excluded for
serum creatinine and 302 for missing serum creatinine and 302 for missing covariates.covariates.
10 year follow-up (median 7.4 years) 10 year follow-up (median 7.4 years) 3209 available for study.3209 available for study.
207 (6%) died, of whom 72 were women207 (6%) died, of whom 72 were women 169 (6%, excluding prevalent CV disease 169 (6%, excluding prevalent CV disease
at baseline) had a major cardiovascular at baseline) had a major cardiovascular event, of whom 68 were womenevent, of whom 68 were women
![Page 18: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/18.jpg)
Results cont’d Results cont’d
Biomarker panel for nine: P<0.001 Biomarker panel for nine: P<0.001 for death and P=0.005 for for death and P=0.005 for cardiovascular eventscardiovascular events
Biomarker panel for ten (2750 Biomarker panel for ten (2750 persons): P<0.001 for death and persons): P<0.001 for death and P=0.04 for cardiovascular events P=0.04 for cardiovascular events
![Page 19: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/19.jpg)
Results cont’dResults cont’d Backward elimination models: final Backward elimination models: final
statistical model included only the statistical model included only the following biomarkers:following biomarkers:
BNP, homocysteine, urinary albumin-BNP, homocysteine, urinary albumin-to-creatinine ratio and renin for to-creatinine ratio and renin for death.death.
BNP and urinary albumin-to-creatinine BNP and urinary albumin-to-creatinine ratio for major cardiovascular events.ratio for major cardiovascular events.
![Page 20: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/20.jpg)
![Page 21: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/21.jpg)
Utility of Multimarker Utility of Multimarker ScoresScores
Backward elimination biomarkers Backward elimination biomarkers selected as statistically significant were selected as statistically significant were incorporated into mulitmarker scores.incorporated into mulitmarker scores.
Restricted to urine sample patients: 1) Restricted to urine sample patients: 1) death from any cause, the number of death from any cause, the number of events and number at risk were 172 and events and number at risk were 172 and 2750, respectively; 2) major 2750, respectively; 2) major cardiovascular events, 133 and 2598, cardiovascular events, 133 and 2598, respectively.respectively.
![Page 22: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/22.jpg)
![Page 23: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/23.jpg)
![Page 24: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/24.jpg)
![Page 25: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/25.jpg)
Utility?Utility? Persons with high multimarker Persons with high multimarker
scores had a risk of death four times scores had a risk of death four times as great and a risk of major as great and a risk of major cariovascular events almost two cariovascular events almost two times as great as persons with low times as great as persons with low mulitmarker scores.mulitmarker scores.
(P<0.001 and P=0.02, respectively) (P<0.001 and P=0.02, respectively)
![Page 26: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/26.jpg)
DiscussionDiscussion ~10 year study of biomarkers ~10 year study of biomarkers
indicating BNP, hsCRP, homocysteine, indicating BNP, hsCRP, homocysteine, renin, and alb/Cr ratio as most renin, and alb/Cr ratio as most informative for predicting death, while informative for predicting death, while BNP and alb/Cr ration as significant BNP and alb/Cr ration as significant for predicting cardiovascular outcome.for predicting cardiovascular outcome.
Although high multimarker scores Although high multimarker scores conferred greater risk for death and conferred greater risk for death and major cardiovascular events…major cardiovascular events…
![Page 27: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/27.jpg)
ConclusionConclusion Mulitmarker scores (combination of Mulitmarker scores (combination of
biomarkers) add only moderately to biomarkers) add only moderately to conventional risk factors as evidenced conventional risk factors as evidenced by small changes in C statistic.by small changes in C statistic.
Single biomarkers may have Single biomarkers may have correlation with predicting outcomescorrelation with predicting outcomes
Panel likely will not be useful or cost-Panel likely will not be useful or cost-effective in ambulatory setting for effective in ambulatory setting for further risk stratification further risk stratification
![Page 28: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/28.jpg)
LimitationsLimitations Biomarker selection: omission of Biomarker selection: omission of
lipoprotein-associated phospholipase A2lipoprotein-associated phospholipase A2 Each individual marker not Each individual marker not
independently testedindependently tested Not a true cohort study to asses for Not a true cohort study to asses for
primary prevention as “nonmajor” primary prevention as “nonmajor” cardiovascular events adjusted cardiovascular events adjusted
Adiposity or insulin resistance not taken Adiposity or insulin resistance not taken into account into account
![Page 29: Cardiology Journal Club](https://reader035.vdocument.in/reader035/viewer/2022081507/568160e2550346895dd011ca/html5/thumbnails/29.jpg)
SummarySummary Biomarkers from multiple, Biomarkers from multiple,
biologically distinct pathways are biologically distinct pathways are associated with the risks of death associated with the risks of death and major cardiovascular events. and major cardiovascular events.
However, only moderately adds to However, only moderately adds to conventional risk factors currently.conventional risk factors currently.